➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
McKinsey
Mallinckrodt
Baxter
Moodys

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Trypan blue - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for trypan blue and what is the scope of patent protection?

Trypan blue is the generic ingredient in two branded drugs marketed by Dorc and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for trypan blue.

Summary for trypan blue
Recent Clinical Trials for trypan blue

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bispebjerg HospitalPhase 4
Lund UniversityPhase 4
ALK-Abelló A/SPhase 4

See all trypan blue clinical trials

Medical Subject Heading (MeSH) Categories for trypan blue

US Patents and Regulatory Information for trypan blue

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for trypan blue

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009   Start Trial   Start Trial
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004   Start Trial   Start Trial
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Medtronic
Dow
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.